Online Only Articles

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Quimatryx, San Sebastian
Quimatryx, San Sebastian
Oncomatryx, Arteaga Auzoa, 43, Derio
Oncomatryx, Arteaga Auzoa, 43, Derio
Department of Organic Chemistry I, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián
Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián
Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián
Mass Spectrometry Platform, CIC biomaGUNE, San Sebastian
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia
Laboratory of Translational Research, Catalan Institute of Oncology (ICO), IDIBELL L’Hospitalet, Barcelona, Catalonia
Department of Hematology, ICO-Hospital Duran i Reynals, IDIBELL, University of Barcelona, L’Hospitalet, Barcelona, Catalonia
Department of Hematology, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia
Department of Hematology, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia
Pathology Service, Fundación Jiménez Díaz, Madrid
Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián
Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L’Hospitalet, Barcelona, Catalonia;Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid;Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L’Hospitalet, Catalonia;Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain
Vol. 103 No. 11 (2018): November, 2018 https://doi.org/10.3324/haematol.2018.189241